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The spleen combines the innate and adaptive immune systems in a uniquely organized
way. The excision of spleen will induce many complications, especially the increased
susceptibility to infections. Recent research shows that besides playing roles during the
immune responses, the spleen is also an important organ during immunoregulation,
which is different from other secondary lymphoid organs. This unique function is mainly
realized by modulating cell migration and proliferation in the spleen. This review provides
a better understanding of the functions of this complex organ gained from recent
studies.
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Introduction
The adaptive immune responses play important roles in anti-infection in vivo and in clearance of
exogenous pathogens. The reactivation of these processes necessitates the contact between antigen-
speciﬁc T/B lymphocytes and antigen-presenting cells carrying corresponding antigens. However,
such contact occurs very rarely in vivo (Gretz et al., 1996; Bajenoﬀ et al., 2006; Cesta, 2006) and
should be realized in secondary lymphoid organs (SLOs). The spleen is a very important SLO. On
a daily basis, a larger count of lymphocytes passes through the spleen than the total count passing
through all other SLOs (Bajenoﬀ et al., 2008). The earliest research shows that the excision of the
spleen will not largely impact the human immune system. However, recent research shows that
this excision will induce many complications, especially the increased susceptibility to infections.
These studies indicate that the spleen plays exclusive roles that cannot be fulﬁlled by other SLOs
(Cadili and de Gara, 2008). Moreover, besides playing roles during immune responses, the spleen is
also an important organ during immunoregulation, which is diﬀerent from other SLOs. The spleen
could decrease the probability of contact between antigen-speciﬁc T/B lymphocytes and antigen-
presenting cells carrying corresponding antigens. In addition, it could also induce the extensive
accumulation of immunosuppressive cells. Moreover, this characteristic is unique to the spleen
among all SLOs. This review focuses on the advances in recent research on the spleen.
Structure of the Spleen
White Pulp and Red Pulp
The spleen is composed of white pulp and red pulp. The white pulp consists of T and B
lymphocytes, which reside in the T-cell zone and the B-cell zone, respectively, rather than mixing
together (Figures 1A,B). Besides T cells, the T-cell zone is ﬁlled with mesenchymal cells, mainly
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FIGURE 1 | Migration of different types of cells in the spleen.
(A) Spleen cryostat sections from C57BL/6 mice were stained for ER-TR7
(green), and imaged using confocal microscopy (Scale bars: 250 μm);
(B) a higher magnification of spleen cryostat sections were observed;
(C) different cell components in the blood enter the marginal sinus, and
diffuse to the marginal zone. T and B cells will first arrive at the T cell
zone. Then follicular Th cells and B cells would move further to the B cell
zone. Moreover, B cells also could shuttle continually between the MZ and
follicles. The dendritic cells, after reactivation, could enter the T cell zone.
MDSCs could be attracted by CCL2 and retained in the MZ and red pulp.
Besides, adhesion molecule VCAM-1in red pulp could retain bone marrow
HSPCs.
ﬁbroblastic reticular cells (FRCs), while the mesenchymal
components of the B-cell zone are mainly ﬁbroblastic dendritic
cells (FDCs; Turley et al., 2010; den Haan et al., 2012). In
addition, the red pulp which surrounds the white pulp is a loose
web-like structure constituted by ﬁbrous tissues. The aging red
blood cells (RBCs) will be cleared away from this structure. The
spleen with rich blood supply is an organ constituted by blood
vessels encircling diﬀerent branches. The blood after entering
the spleen will pass through diﬀerent levels of artery branch
vessels. Finally, a part of the blood mingles into themarginal sinus
(between the marginal zone and the white pulp); the other part
directly enters the blood sinus in the red pulp and ﬁnally ﬂows
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outside the spleen through the splenic veins. Speciﬁcally, the
lymphocytes after entering the marginal sinus can directionally
migrate to the surroundings of the central artery in the arterial
terminal branches (Mebius and Kraal, 2005; Cesta, 2006) to form
white pulp. On the contrary, other cell components will ﬂow
along with the blood into the red pulp. The red pulp contains
abundant phagocytes, which will clear away the old RBCs and the
pathogenic microorganism (den Haan et al., 2012).
The Marginal Zone
This zone resides between the splenic white pulp and red pulp.
This structure is unique among all splenic SLOs (Figure 1B).
In this zone, abundant macrophages termed marginal-zone
macrophages and marginal-zone metallophilic macrophages
(MMMs), as well as dendritic cells (DCs) designated as marginal-
zone DCs, and B cells (Bajenoﬀ et al., 2008) pathogenic
microorganism and aging cells will be largely swallowed by the
macrophages, while the DCs will ingest the antigens. Moreover,
the lymphocytes ﬂowing into the blood will stay for a short
period before entering the white pulp. The lymphocyte and the
reactivated antigen-presenting cells, after arriving at the marginal
zone, will enter the white pulp along speciﬁc routes, rather
than randomly. In the MOMA-1-positive marginal zone, the
macrophages will constitute a ring-like structure surrounding the
white pulp, which helps to fully isolate the white pulp and the
marginal zone. However, this ring-like structure is not perfect,
since it has a gap. These cells are called marginal-zone B cells
(MZBCs). This gap is a channel where various cells enter the
white pulp. Interestingly, MZBCs only exist around the T-cell
zone in the white pulp, rather than the B-cell zone (Bajenoﬀ
et al., 2008). These facts increase the probability of contact
between the antigen-speciﬁc T/B lymphocytes and the antigen-
presenting cells carrying corresponding antigens. For example,
the antigen-presenting cells after activation would migrate to
in the T-cell zone and retain there. The antigen-speciﬁc T cells
migrate along the speciﬁc track into and out of the T-cell zone.
These abilities allow T cells to move throughout the entire T-cell
zone. As a result, the probability of contact between the antigen-
speciﬁc T lymphocytes and the antigen- presenting cells carrying
corresponding antigens could be maximized. On the contrary,
this probability would be reduced greatly if the T cells canmigrate
into and out of the splenic T-cell zone randomly. Moreover, the
marginal zone also contains a speciﬁc B cell subzone. MZBCs
which reside between the marginal zone and the red pulp can
capture antigens carried in the blood via complement receptors,
and promote both T-cell-independent and -dependent immune
responses.
Conduit System
There is a special harrow 3D web-like structure in the
SLOs, which is constituted by FRCs as well as the FRCs-
secreted extracellular matrix (ECM). These FRCs mainly express
podoplanin (gp38), but not the lymphatic and blood endothelial
cell marker: platelet endothelial cell adhesion molecule (PECAM,
CD31; Mueller and Germain, 2009; Malhotra et al., 2013). The
FRCs wrap up a harrow microtubule system, constituted by
the FRCs-secreted ECMs. The microtubule system in the SLOs
can be detected by ER-TR7 (Alvarenga and Marti, 2014). The
diameter of the microtubules is usually 4–5 nm, which are only
accessible to molecules smaller than 70 KD. The distributive
characteristics of these microtubules in the lymph nodes (LNs)
have been thoroughly studied, but those in the spleen are unclear.
It is deduced that one end of a microtubule is located in the
B-cell zone and particularly the T-cell zone, while the other end is
located in the red pulp or the marginal zone. With the presence of
these microtubules in the spleen, the micro- molecular antigens
can rapidly pass from the blood to the T-cell zone. Though these
microtubules are distributed rarely in the B-cell zone, conduits
may also serve as a pathway for low-molecular-weight antigens
to reach follicles and facilitate B cell responses (Stranford and
Ruddle, 2009).
Directed Migration of Different Cells in
the Spleen
The directed migration of diﬀerent cell components is regulated
by chemokines (Table 1), especially CCL21, CCL19, and
CXCL13. The FRCs in the T-cell zone secrete CCL21 and CCL19,
while after binding to the receptor CCR7 in T cells, they can
chemoattract T cells (Ueha et al., 2011; Ugel et al., 2012). The
FDCs in the B-cell zone secrete CXCL13, which functions by
acting on its receptor CXCR5. CXCL13 guides B cells and
follicular T helper (Th) cells into the B cell zone. The critical
roles of these homeostatic chemokines in attracting cells into
lymphoid organs and in initiating the antigen-speciﬁc responses
are well-established (Mueller et al., 2007).
TABLE 1 | Main chemokines and molecules in the spleen.
Chemokines
and molecules
Receptor Target cells Expression
regions
Promoting
production
Inhibiting
production
Producing cells Function
CCL21 CCR7 T cells; DCs T cell zone LTs and TNFs IFN-r Mainly by FRCS Attracting T cells
CCL19 CCR7 T cells; DCs T cell zone LTs and TNFs IFN-r Mainly by FRCS Attracting T cells
CXCL13 CCR5 B cells; Th cells B cell zone LT-B IFN-r Mainly by FDCS Attracting B cells
IL7 IL7R T cells T cell zone LT-B IFN-r and TGF-β1 Mainly by FRCS T cell homeostasis
CCL2 CCR2 MDSCs Margin zone;
red pulp
Unknown Unknown Nestin+ splenocytes Attracting MDSCs
S1P S1PR1; S1PR3 B cells Margin zone Unknown Unknown LyVE-1+ cells Attracting B cells
VCAM-1 VLA-4 HPSCs Red pulp Unknown Unknown VCAM-1+ macrophages Attracting HPSCs
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First, the diﬀerent cell components in the blood will enter
the marginal sinus through all levels of vascular branches, and
thereby diﬀuse to themarginal zone. In this zone, the T and B cells
will ﬁrst adhere to the ER-TR7-positive ﬁberweb-like structure
and migrate along the fasciculus in an oriented way. They ﬁrst
arrive at the marginal zone bridging channels (MZBCs) and then
at the T-cell zone. The diﬀerentiation of T cells into follicular T
helper (Th) cells will induce expression of CXCR5 in Th cells.
Then Th cells and B cells would move further until arrive at the
B-cell zone (Pereira et al., 2010).
Moreover, B cells express the chemokine receptor CXCR5 and
thus can respond to the follicular attracting activity mediated
by its ligand CXCL13. However, B cells could also overcome
such activity by largely expressing the sphingosine-1 phosphate
(S1P) receptors-1 and -3 (S1PR1, S1PR3). The binding of the
lysophospholipid S1P which produced by LyVE-1+ cells to these
receptors will trigger a chemotactic response and promote the
accumulation of B cells in the marginal zone and red pulp which
contains higher concentrations of S1P. Nevertheless, intravital
microscopy studies indicate that MZBCs shuttle continually
between the marginal zone and follicles. The mechanisms that
control such oscillatory migration involves transient S1PR1
desensitization (for migration from the marginal zone into the
follicles), followed by S1PR1 resensitization (for migration back
to the marginal zone; Mehta et al., 2014). Moreover, the marginal
zone is also permanently planted with many DCs, which, after
digestion and reactivation with antigens, can express CCR7.
Through the movement orbit of T cells, they could enter the
T-cell zone and reactivate the antigen-speciﬁc T cells (Turley
et al., 2010).
Just as mentioned before, except some kinds of cells (e.g.,
T cells, B cells, and DCs), other cells will ﬂow along the
blood stream into the red pulp. Myeloid-derived suppressor cells
(MDSCs) which express CCR2 could be attracted by CCL2 and
retain in the red pulp. Besides, bone marrow hematopoietic
stem/progenitor cells (HSPCs) also could retain in the red pulp
by vascular cell adhesion molecule 1 (VCAM-1)+ macrophages,
which use the adhesion molecule VCAM-1 to retain HSPCs
through its receptor – very late antigen 4 (VLA-4; Bronte and
Pittet, 2013). In certain condition, a large amount of MDSCs
or HSPCs could accumulate in the red pulp and inﬂuence the
immune response. In the end, rest of the cells would ﬂow out of
the spleen along the blood stream (Figure 1C).
Regulation of Chemokine Secretion
The expressions of CCL21 and CCL19 by FRCs in the splenic
T cell zone and LNs facilitate the eﬀective interaction between
DCs and T cells (Luther et al., 2011). The secretion of these
chemokines in SLOs is not constant, but can be regulated by
diﬀerent molecules. Firstly, previous research shows that the
mesenchymal cells of SLOs require continuous signals from
many molecules, so as to maintain their secretion of CCL21
and 19. The most-studied molecules are the tumor necrosis
factor (TNF) family members. For example: LTs and TNFs are
among such signaling molecules (Klaus et al., 1980; Schneider
et al., 2004; Zhao et al., 2015). The deletion of these factors will
induce the down-regulation of CCL21 and CCL19. However, the
redundancy in TNF/LT ligand-receptor interactions complicates
the understanding about the distinct contribution of particular
ligand to the complex phenotype of TNF/LT-deﬁcient mice
(Tumanov et al., 2003; Zhao et al., 2014). In addition, these
maintaining factors are mainly secreted by lymphocytes (Sixt
et al., 2005; Zhao et al., 2014). As reported, the deletion of T
cells will also lead to the signiﬁcantly down-regulated secretory
volumes of CCL19 and CCL21, and the expression levels of
these chemokines can be recovered after the transfusion of T
cells. Even the maintaining eﬀects of these factors have not
changed, some molecules also could directly down-regulate the
expressions of CCL21 and CCL19. For instance, upon infection,
the reactivated T cells will secrete abundant IFN-r, which will
induce the down-regulated expressions of CCL21 and CCL19,
and thereby down-regulate the immune response of T cells upon
the next infection (Mueller et al., 2007; Li et al., 2014). In addition,
expressions of CCL21 and CCL19were also reduced in the spleen
of Inﬂammatory Melanomas, but the reasons were not very clear
(Soudja et al., 2011).
TABLE 2 | Effects of chemokine disorders on splenic microenvironments.
Spleen
region
Marginal zone T cell zone B cell zone Red pulp
Chemokine
change
Effect Chemokine
change
Effect Chemokine
change
Effect Chemokine
change
Effect
Infection Unknown Unknown CCL21↓;
CCL19↓
Inhibiting migration of
T cells to T cell zone
CXCL13↓ Inhibiting migration of
B cells to B cell zone
Unknown Unknown
Tumor CCL2↑ MDSCs
accumulation
Unknown Unknown Unknown Unknown CCL2↑ MDSCs accumulation
Neonatal Unknown Unknown Unknown Unknown Unknown Unknown Unknown CD71+ erythroid progenitor
cells accumulation
Anemia Unknown Unknown Unknown Unknown Unknown Unknown Unknown CD71+erythroid progenitor
cells accumulation
HIV Unknown Unknown IL7↓ T cells depletion Unknown Unknown Unknown Unknown
Inflammatory
melanomas
CCL2↑ MDSCs
accumulation
CCL21↓;
CCL19↓
Inhibiting migration of
T cells to T cell zone
Unknown Unknown CCL2↑ MDSCs accumulation
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The chemokine CXCL13 is made broadly by follicular DCs
(FDCs). Regulation of CXCL13 is much like the pattern of
CCL21 and CCL19. Expression of CXCL13 is dependent on
the cytokine lymphotoxin (LT)-B and a positive feedback loop
involving CXCR5-mediated induction of LT-B expression by B
cells contributes to maximal CXCL13 production and maturation
of the FDC network. In addition, production of IFN-r also
inhibits the expressions of CXCL13 which could inhibit B cells
movement (Li et al., 2014).
Besides CCL21 and CCL19, the stromal cells FRCs can also
secrete IL7 and participate in maintaining the homeostasis of T
cells (Zhao et al., 2014). This secretion is mainly regulated by
LT-B. The LT-B in the T-cell zone of SLOs is mainly secreted by
T cells. Among acquired immune deﬁciency syndrome (AIDS)
patients, the reduced count of T cells in SLOs will lead to
the reduced secretion of LT-B and thus impact the secretion
of IL7 (Sixt et al., 2005). Previous researches show that T
regulatory cells could promote the procollagen production and
subsequent deposition as ﬁbrils via the TGF-β1 signaling pathway
and chitinase 3-like-1 activity in ﬁbroblasts in lymphoid tissues
from human immunodeﬁciency virus (HIV)-1-infected patients.
Collagen deposition restricts the access of T cell to the survival
factor IL-7 on the FRC network, resulting in apoptosis and
depletion of T cells, which in turn removes a major source of
lymphotoxin-β (Fry and Mackall, 2005; Levy et al., 2009; Zeng
et al., 2011, 2012).
Production of CCL2, which could induce a large amount of
accumulation of MDSCs through CCR2, is strongly increased in
tumor-bearing mice, and nestin+ splenocytes clearly participate
in the increase in chemokine production in tumor- bearing hosts.
These cells were rarely detectable in the spleen of tumor-free mice
(Ugel et al., 2012).
The Role of Blood Flow
Moreover, though not conﬁrmed, we speculate that the blood
ﬂow rate in the spleen will also aﬀect the speeds of diﬀerent
cell components entering the spleen. The reason is that when
the expressions of various chemokines are unchanged, the blood
ﬂow rate will directly determine the speeds of diﬀerent cell
components entering the spleen, thereby impacting the speed
of immune response. In clinic, the key factors that induce the
changes of blood ﬂow rate in the spleen are the blood pressure
and the size of the spleen. When other conditions are not
changed, the blood ﬂow will change with the variation of blood
pressure. When the blood pressure is unchanged, the increase
of spleen size will accelerate the blood ﬂow in the spleen. This
may also explain why the spleen expands upon the onset of
chronic infection in many patients. Therefore, the pathogen
clearance rate can be improved by increasing the blood ﬂow in
the spleen.
Immunosuppressive Cells
Myeloid-derived suppressor cells as immature myeloid cells
are the precursors of DCs, macrophages, and/or granulocytes.
Previous research shows that it is mainly distributed in the
marginal zone and red pulp of the spleen (Ugel et al., 2012). The
contents of immunosuppressive substances vary among MDSCs,
with diﬀerent populations containing arginase, inducible NO
synthase, and/or additional ROS. Their accumulation has been
documented in most patients and mice with cancer, which is
induced by various factors produced by tumor cells and/or
host cells in the tumor microenvironment. These substances
will also accumulate in response to bacterial or parasitic
infection, chemotherapy, experimentally induced autoimmunity,
and stress. MDSCs are considered as a major contributor
to the profound immune dysfunction of most patients with
sizable tumor burdens (Ostrand-Rosenberg et al., 2012; Ugel
et al., 2012). Previous research shows that these cells express
CCR2, whose ligand is CCL2. Accumulation of MDSCs in
the spleen could cause by increased production of CCL2
(Table 2). However, recent researches show that these cells
also could proliferate in the spleen in certain condition. This
also play an important role in the accumulation of these
cells.
Moreover, as reported, bone marrow HSPCs can enter
circulation in the steady-state. If conditions permit, the
circulating HSPCs will produce lineage-descendant cells outside
the bone marrow. This so-called extramedullary hematopoiesis
occurs predominantly in the liver in the developing embryo,
but also in adult tissues including the spleen. Red pulp
vascular cell adhesion molecule 1 (VCAM-1)+ macrophages
are essential to extramedullary myelopoiesis because these
macrophages use the adhesion molecule VCAM-1 to retain
HSPCs in the spleen red pulp. Indeed, under speciﬁc disease
conditions, splenic HSPCs will profoundly expand. Splenic
hematopoiesis has been reported in animal models of several
diseases, including cancer, atherosclerosis myocardial infarction,
and colitis (Cortez-Retamozo et al., 2012; Bronte and Pittet,
2013). However, there is no report whether these cells are
active during immunoregulation. Nevertheless, recent research
shows that CD71+ erythroid progenitor cells are physiologically
enriched in neonatal mice, and CD71+ cells are produced
after extensive proliferation and diﬀerentiation of HSPCs.
These cells show immunosuppressive properties which could
inhibit microphage function (Table 2). Speciﬁcally, the count
of CD71+ erythroid cells in the spleens of new-born mice
is signiﬁcantly larger than that in mature mice. Moreover,
Neonatal CD71+ cells express the enzyme arginase-2 and
play important roles in the immunosuppression of new-born
mice, which are diﬀerent from mature mice (Elahi et al.,
2013).
Conclusion
The spleen undertakes important roles in SLOs, such as
clearance of antigens from the blood, and generation of speciﬁc
immune responses. Moreover, the spleen plays important roles
in regulation of immune responses. Many functions of the spleen
are unique and irreplaceable among other SLOs. Finally, more
studies on the spleen are needed before dismissing its importance.
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